Avoro Capital Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,670,000
| Closed | -$11.4M | – | 43 |
|
|
2022
Q1 | $11.4M | Hold |
1,670,000
| – | – | 0.21% | 38 |
|
|
2021
Q4 | $13.5M | Sell |
1,670,000
-605,000
| -27% | -$4.89M | 0.23% | 36 |
|
|
2021
Q3 | $22.3M | Sell |
2,275,000
-2,090,000
| -48% | -$20.5M | 0.35% | 36 |
|
|
2021
Q2 | $29.4M | Hold |
4,365,000
| – | – | 0.51% | 31 |
|
|
2021
Q1 | $39.5M | Hold |
4,365,000
| – | – | 0.68% | 31 |
|
|
2020
Q4 | $29.2M | Buy |
4,365,000
+165,000
| +4% | +$1.1M | 0.5% | 30 |
|
|
2020
Q3 | $21.2M | Sell |
4,200,000
-365,655
| -8% | -$1.84M | 0.3% | 35 |
|
|
2020
Q2 | $36.9M | Buy |
4,565,655
+200,000
| +5% | +$1.62M | 0.73% | 27 |
|
|
2020
Q1 | $34.7M | Buy |
+4,365,655
| New | +$34.7M | 1.17% | 21 |
|
|
2015
Q3 | – | Sell |
-267,747
| Closed | -$5.67M | – | 31 |
|
|
2015
Q2 | $5.67M | Buy |
267,747
+52,042
| +24% | +$1.1M | 1.56% | 18 |
|
|
2015
Q1 | $3.88M | Buy |
215,705
+900
| +0.4% | +$16.2K | 1.49% | 19 |
|
|
2014
Q4 | $3.68M | Buy |
+214,805
| New | +$3.68M | 2.49% | 14 |
|